U.S. street drug deaths keep dropping, but some Western states see deadly overdose surge

U.S. overdose deaths dropped 14% in 2025, reaching 69,973 nationwide—the lowest in at least six years—according to preliminary CDC data. This marks a continued decline from 2024, with roughly 11,300 fewer fatalities, though the toll remains historically high compared to other countries. Dr. Nora Volkow of the National Institute on Drug Abuse (NIDA) called the trend 'very good news,' attributing progress to expanded access to medications like naloxone (Narcan), which reverses opioid overdoses. Public health experts highlight structural improvements, including widespread naloxone distribution and reduced potency of illicit fentanyl. Beth Meyerson, director of the University of Arizona’s Harm Reduction Research Lab, emphasized that naloxone is now treated as critical first aid in communities. Additional factors include fewer young people using drugs and targeted interventions in states like New York, where opioid deaths from fentanyl, heroin, and black-market pain pills have halved since 2022. Three states—Alabama, New York, and Virginia—experienced dramatic declines, with 25-30% fewer overdose deaths in the year ending December 2025. New York Governor Kathy Hochul noted the progress but stressed ongoing efforts to address health disparities and emerging drug threats. Nationally, 2025 marked the first time since 2019 that overdose deaths fell below 70,000, a stark contrast to the peak of 112,418 deaths in mid-2023. Despite the national trend, some Western states report worsening outbreaks, offsetting the overall decline. The U.S. death rate remains significantly higher than in countries like Scotland, which has the second-highest overdose rate globally but far fewer fatalities per capita. Experts caution that while progress is evident, sustained efforts are needed to combat persistent disparities and evolving drug supply threats.